Derma Sciences Cmn (DSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,814 | 19,397 | 6,502 | 41,617 | 17,110 |
| Marketable Securities | 25,004 | 55,996 | 15,478 | 3,730 | 5,225 |
| Receivables | 8,146 | 8,758 | 7,333 | 7,086 | 6,268 |
| Inventories | 20,691 | 13,281 | 16,473 | 13,671 | 10,531 |
| Other current assets | 0 | 814 | 0 | 0 | 0 |
| TOTAL | $71,104 | $100,836 | $49,532 | $69,312 | $41,233 |
| Non-Current Assets | |||||
| PPE Net | 4,129 | 3,614 | 2,954 | 3,305 | 3,489 |
| Investments And Advances | 16,110 | 8,423 | 7,858 | 498 | 249 |
| Intangibles | 23,289 | 26,273 | 28,094 | 30,587 | 13,523 |
| Other Non-Current Assets | 148 | 144 | 139 | 141 | 130 |
| TOTAL | $43,676 | $38,454 | $39,045 | $34,531 | $17,391 |
| Total Assets | $114,780 | $139,291 | $88,576 | $103,843 | $58,624 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,473 | 3,676 | 4,523 | 3,994 | 4,000 |
| Accrued Expenses | 6,691 | 5,523 | 4,969 | 4,133 | 2,378 |
| TOTAL | $13,535 | $11,511 | $9,492 | $8,127 | $6,378 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,014 | 521 | 242 | 269 | 253 |
| TOTAL | $2,819 | $2,215 | $1,937 | $2,005 | $1,399 |
| Total Liabilities | $16,354 | $13,726 | $11,428 | $10,131 | $7,776 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,885 | 25,701 | 25,132 | 16,621 | 10,631 |
| Common Shares | 259 | 253 | 174 | 165 | 106 |
| Retained earnings | -142,050 | -103,942 | -64,171 | -40,207 | -28,136 |
| Other shareholders' equity | 5,274 | 912 | 1,081 | 1,590 | 1,503 |
| TOTAL | $98,426 | $125,565 | $77,148 | $93,711 | $50,848 |
| Total Liabilities And Equity | $114,780 | $139,291 | $88,576 | $103,843 | $58,624 |